• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (2)
    • Lockett, Mark
    • Rho/ROCK pathway as a target of tumor therapy.
    • See All 2 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Rho/ROCK pathway as a target of tumor therapy.

Rho/ROCK pathway as a target of tumor therapy. J Neurosci Res. 2006 Feb 01; 83(2):243-55.

View in: PubMed

subject areas
  • Amides
  • Animals
  • Antineoplastic Agents
  • Apoptosis
  • Blotting, Southern
  • Blotting, Western
  • Caspases
  • Cell Survival
  • Disease Models, Animal
  • DNA Fragmentation
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Enzyme Inhibitors
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Intracellular Signaling Peptides and Proteins
  • Lovastatin
  • Male
  • Mevalonic Acid
  • Mice
  • Neoplasms
  • Neoplasms, Experimental
  • Polyisoprenyl Phosphates
  • Pyridines
  • Rats
  • Rats, Wistar
  • rhoA GTP-Binding Protein
  • rho-Associated Kinases
  • Signal Transduction
  • Tetrazolium Salts
  • Thiazoles
  • Time Factors
  • Tumor Cells, Cultured

authors with profiles
  • Inderjit Singh